Histidine-Tryptophan-Ketoglutarate and University of Wisconsin Solution Demonstrate Equal Effectiveness in the Preservation of Human Pancreata Intended for Islet Isolation: A Large-Scale, Single-Center Experience

Histidine-Tryptophan-Ketoglutarate for Pancreas Allograft Preservation: The Indiana University Experience

(2010) J. A. Fridell et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Histidine-Tryptophan-Ketoglutarate (HTK) Is Associated with Reduced Graft Survival of Deceased Donor Kidney Transplants

(2009) Z. A. Stewart et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Pancreas preservation for pancreas and islet transplantation

(2009) Yasuhiro Iwanaga et al.   Current Opinion in Organ Transplantation

Histidine-Tryptophan-Ketoglutarate (HTK) Is Associated with Reduced Graft Survival in Pancreas Transplantation

(2008) Z. A. Stewart et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Islet Transplantation for Brittle Type 1 Diabetes: The UIC Protocol

(2008) A. Gangemi et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Histidine-Tryptophan-Ketoglutarate (HTK) Is Associated with Reduced Graft Survival in Deceased Donor Livers, Especially Those Donated After Cardiac Death

(2008) Z. A. Stewart et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Increased Albumin Concentration Reduces Apoptosis and Improves Functionality of Human Islets

(2008) Barbara Barbaro et al.   ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY

A prospective randomized multicenter trial comparing histidine-tryptophane-ketoglutarate versus University of Wisconsin perfusion solution in clinical pancreas transplantation

(2008) Stefan Schneeberger et al.   TRANSPLANT INTERNATIONAL

Greater Hemodynamic Instability With Histidine-Tryptophan-Ketoglutarate Solution Than University of Wisconsin Solution During the Reperfusion Period in Living Donor Liver Transplantation

(2008) J.S. Ko et al.   TRANSPLANTATION PROCEEDINGS